Ownership period: 1915-2002
Turnover:2.5 Bio. DKK
Creation of iconic Chewing Gum brands like Stimorol®, Dirol® and V6®
Brands, factory in Russia and all sales subsidiaries divested to Cadbury Schweppes in 2002 in order for the branded business to take part in a global consolidation within chewing gum and confectionery. Bagger-Sørensen family retained ownership of all B2B related activities continuing in Gumlink A/S.
Ownership period: 2002 ->
B2B Chewing gum –> obtaining +60% SOM in European Private Label from 2002 -> 2008
Strong Operational Model developed and implemented allowing industry leading productivity performance and Customer Service.
Transformation in 2009 based on decision to globalize and improve competitiveness through formation of several Joint Ventures (India, Zimbabwe/South Africa, Mexico, Canada and Turkey). Manufacturing in Denmark seized in 2012 and Gumlink A/S became a holding company for Joint Venture investments within confectionery.
Ownership period: 1978->
Shareholding: 70% of shareholding divested to EQT in 2017
Turnover: 1.0 Bio. DKK
Industry leading quality standards and global foot print
Strong innovation capabilities and Intellectual Property portfolio
Initially, established Fertin Pharma A/S as the largest CDMO within pharmaceutical chewing gum and smoking cessation gum. Further, developed the company into a world leading CDMO within convenient and pleasurable oral and intra-oral delivery systems across Pharma and Nutraceuticals working with multiple top tier global Pharma and Consumer Health companies.
Ownership period: 2010 ->
Turnover: ~500 mio DKK
Double digit growth year on year
Global B2B sales and own Brands in Turkey/Middle East
Strong combination of own brands in Middle East/Turkey and B2B business model in rest of the world fueled by large scale modern manufacturing in a cost competitive environment coupled with strong innovation and R&D capabilities.
Industry: Nutraceuticals and Food
Ownership period: 2011-2018
Turnover increased from 2.5 Mio. CAN to 15 Mio. CAN
Significant increase in EBITDA
Facility in Langley, Vancouver, Canada upgraded, expanded and BRC (A) and Canada Health certified
Business was diversified into Nutraceuticals. Improved Product Development, Sales and Operations enabling attraction of large MLM customers in US, Canada and China.